Using genome engineering to combat HIV-1
Gang Wang explores strategies for inactivating or eradication the HIV provirus in the genome of long-lived resting T cells and other cell types. These 'reservoir cells' are not affected by combined antiretroviral therapy, currently the standard treatment for HIV-1. This means the virus can quickly rebound from this reservoir if the therapy is interrupted. Genome engineering therefore offers potential strategy towards developing a real cure for HIV.
G. Wang: CRISPR-Cas based Strategies against HIV-1. Promotor is prof. dr. B. Berkhout. Copromotor is dr. A.T. Das.
Prof. B. Berkhout
Dr A.T. Das
Oudezijds Voorburgwal 229 - 231 | 1012 EZ AmsterdamGo to detailpage
+31 (0)20 525 2362
This event is open to the public.